MMedication Read More Artelo ART26.12 Osteoarthritis Study: Relief Like Naproxen17 July 2026 Artelo Biosciences (Nasdaq: ARTL) reported new nonclinical data showing its selective FABP5 inhibitor ART26.12 reduced…